Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

This study has been completed.

First Received: July 3, 2001 Last Updated: January 20, 2009 History of Changes

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00018343

Purpose

This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

Condition	Intervention	Phase
Alzheimer's Disease	Drug: estrogen	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title:	Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Resource links provided by NLM:

Genetics Home Reference related topics: Alzheimer disease

MedlinePlus related topics: Alzheimer's Disease

U.S. FDA Resources

Further study details as provided by Department of Veterans Affairs:

Study Start Date:	April 1998
Estimated Study Completion Date:	March 2001

Eligibility

Ages Eligible for Study:	50 Years to 90 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Post menopausal women with alzheimer's disease
free of any major medical or neurological disease,
medically safe to be treated with estrogen.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018343

Locations

United States, Washington
VA Puget Sound Health Care System
Lakewood, Washington, United States, 98493-5000

Sponsors and Collaborators

Department of Veterans Affairs

Investigators

Investigator:	Suzanne Craft, Ph.D
Investigator:	Laura Baker, Ph.D
Investigator:	Murray Raskind, M.D.

More Information

No publications provided

Study ID Numbers:	AGCG-007-97F
Study First Received:	July 3, 2001
Last Updated:	January 20, 2009
ClinicalTrials.gov Identifier:	NCT00018343 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Estrogens
Hormone Antagonists
Alzheimer Disease
Hormones, Hormone Substitutes, and Hormone Antagonists
Central Nervous System Diseases
Brain Diseases
Neurodegenerative Diseases

Hormones
Cognition Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Dementia
Delirium

Additional relevant MeSH terms:

Estrogens
Alzheimer Disease
Nervous System Diseases
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Central Nervous System Diseases
Brain Diseases

Neurodegenerative Diseases
Hormones
Pharmacologic Actions
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Dementia
Tauopathies

ClinicalTrials.gov processed this record on September 04, 2009